Applied Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
14/05/2025 21:41
Applied Therapeutics Inc APLT.OQ reported a quarterly adjusted loss of 15 cents per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -67 cents. The mean expectation of four analysts for the quarter was for a loss of 19 cents per share. Wall Street expected results to range from -22 cents to -16 cents per share. Reported revenue was zero; analysts expected $4.58 million. Applied Therapeutics Inc's reported EPS for the quarter was a loss of 15 cents. The company reported a quarterly loss of $21.83 million. Applied Therapeutics Inc shares had fallen by 10.0% this quarter and lost 48.6% so far this year. FORECAST CHANGES The mean earnings estimate of analysts had fallen by about 67.7% in the last three months. In the last 30 days, two analysts negatively revised earnings estimates RECOMMENDATIONS The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." Wall Street's median 12-month price target for Applied Therapeutics Inc is $2.50 This summary was machine generated from LSEG data May 14 at 08:41 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| Mar. 31 2025 | -0.19 | -0.15 | Beat |
| Dec. 31 2024 | -0.18 | 0.33 | Beat |
| Sep. 30 2024 | -0.16 | -0.48 | Missed |
| Jun. 30 2024 | -0.16 | 0.02 | Beat |